Apixaban for treatment of intracardiac thrombosis in children with congenital heart disease.
暂无分享,去创建一个
[1] J. Newburger,et al. A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study. , 2019, American heart journal.
[2] J. Newburger,et al. PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)—Rationale and Design , 2019, Thrombosis and Haemostasis.
[3] R. de Caterina,et al. Apixaban Compared with Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the ARISTOTLE Trial , 2015 .